Verwandte Artikel zu Cancer Vaccines: Challenges and Opportunities in Translation

Cancer Vaccines: Challenges and Opportunities in Translation - Softcover

 
9780367387556: Cancer Vaccines: Challenges and Opportunities in Translation
Softcover
ISBN 10: 0367387557 ISBN 13: 9780367387556
Verlag: CRC Press, 2019

Inhaltsangabe

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.





Cancer Vaccines: Challenges and Opportunities in Translation:





  • Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential


  • Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy


  • Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer


  • Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

ADRIAN BOT is Senior Director of Scientific Management and Acting Head of Translational Medicine at MannKind Corporation, in Valencia, California. He obtained his M.D. at the University of Medicine and Pharmacy in Timisoara, Romania and his Ph.D. in Biomedical Sciences at Mount Sinai School of Medicine in New York. He previously held appointments at the Scripps Research Institute and Alliance Pharmaceutical Corporation in San Diego. Dr. Bot authored more than one hundred publications and patents in oncology, vaccines, drug delivery technologies and immunotherapy. He is the Editor-in-Chief of the International Reviews of Immunology and has been on advisory boards of several organizations.





MIHAIL OBROCEA is Vice President, Clinical Development, MannKind Corporation, Paramus, New Jersey. Dr. Obrocea received his M.D. from the Faculty of Medicine and Pharmacy, Bucharest, Romania. He is a medical oncologist with over 10 years of academic and industry experience in oncology clinical trials, including biologic agents, small molecules and cytotoxic agents. Dr. Obrocea has published in oncology peer-reviewed literature, and has various patents in the field of biotechnology.

Von der hinteren Coverseite

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
CRC Press
Erscheinungsdatum
2019
Sprache
Englisch
ISBN 10 
0367387557
ISBN 13 
9780367387556
Einband
Taschenbuch
Auflage
1
Anzahl der Seiten
217
Herausgeber
Bot Adrian, Obrocea Mihail
Kontakt zum Hersteller
CRC Press
https://www.routledge-ny.com

6000 BROKEN SOUND PARKWAY, NW SUITE 300
BOCA RATON
FL
33487
USA
Verantwortliche Person
GPSR Kontakt
gpsr@libri.de

Europaallee 1
Bad Hersfeld
36244
Deutschland